Overall, these results concluded that MAFG-AS1 knockdown inhibited the proliferation, migration, invasion, and tumor growth of drug-resistant HCC cells in vitro, suggesting the potential tumor-promoting role of MAFG-AS1 in drug resistance of HCC. This evidence concerns the gene MAFG and hepatocellular carcinoma.